Story
Latigo Biotherapeutics Shares Rise 17% in Market Debut After Upsized $346M IPO

Shares of Latigo Biotherapeutics (NASDAQ: LTGO) surged 17% in their trading debut Friday after the company raised $345.6 million in an upsized initial public offering. The strong market reception highlights investor interest in the company's development of non-opioid pain medication.
Offering Details
Latigo Biotherapeutics sold 19.2 million shares at $18 per share, the top of its marketed range of $16 to $18, according to a company announcement. The offering was increased from the initially planned 16 million shares, a sign of robust demand from institutional investors.
The gross proceeds of the offering total $345.6 million before deducting underwriting discounts and commissions. Underwriters also have a 30-day option to purchase up to an additional 2.88 million shares. The offering is expected to close on August 10, 2026.
Market Debut
Latigo's stock opened for trading on the Nasdaq Global Select Market at $21 per share. The successful IPO gives the Thousand Oaks, California-based company a market valuation of approximately $1.3 billion, based on the number of outstanding shares listed in its filings.
AdCompany Background
Latigo Biotherapeutics is a clinical-stage company focused on developing non-addictive pain medicines. Its lead product candidate, LTG-001, is an oral Nav1.8 inhibitor designed to treat acute pain without the risks associated with opioids. The company is backed by Blue Owl Capital Inc.
The IPO was managed by a syndicate of banks, with key roles including:
- Goldman Sachs & Co. LLC
- Jefferies
- Leerink Partners
- Guggenheim Securities
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.